NN7008-3553 A Multi-centre Non-interventional Study of Safety and Efficacy of turoctocog alfa (rFVIII) during Long-Term Treatment of Severe and Moderately Severe Haemophilia A (FVIII ≤2%) (guardian™ 5)

First published 10/01/2014

Last updated 22/02/2024

EU PAS number:

EUPAS5501

Study

Finalised

Documents

Study protocol

Initial protocol

3553-protocol-version-3_Redacted

English (407.2 KB - PDF)View document

Updated protocol

3553-protocol-version-8-redacted

First published: 22/02/2024

English (425.71 KB - PDF)View document

Study results

3553 nsr version 2 eu-pas-reg redacted

English (1.88 MB - PDF)View document

Study report

3553-eu-pass-progress-report-20160519

English (536.71 KB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs